Answers are grounded in this paper and cite their sources.
Packaging drugs and genes into nanoparticles enables drug or gene biodistribution to be favourably altered, with an ultimate therapeutic benefit [1–3]. To acquire such control on the in vivo fate of drugs and genes requires that such particles be precision engineered and electron microscopy is one of the techniques used to visualise and confirm the results of such engineering.
No takes yet. Share an insight, caveat, or question.
Ijeoma F. Uchegbu (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: